Comments on the failure of intensive self-regulatory treatment with chronic daily headache.
Non-pharmacological therapy of primary headache conditions including chronic daily headache (CDH) is not well-studied.  Barton and Blanchard report on their experience with intensive self-regulatory treatment in a cohort of patients with CDH.  This negative trial provides preliminary observations that need further investigations in controlled, adequately powered clinical study.
Ramadan
N M
NM
Lilly Research Laboratories, A divisio of Eli Lily & Co., Lilly Corporate Center, Drop Code 1730, Indianapolis, Indiana 46285. ramadan_nabih@Lilly.com
D000328:Adult; D001676:Biofeedback, Psychology; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D005260:Female; D020773:Headache Disorders / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009126:Muscle Relaxation; D012107:Research Design; D012648:Self Care; D017211:Treatment Failure